News / Business
PAREXEL International Corporation (PRXL) to Speak at Raymond James Annual Investor Conference March 3
PAREXEL International Corporation (NASDAQ:PRXL) will speak that the Raymond James Annual Investor Conference on March e at 12:00 pm.
A bio/pharmaceutical services company, PAREXEL provides capability in clinical research, medical communications services, consulting and informatics and technology products and services to the worldwide pharmaceutical, biotechnology and medical device industries.
Company products include clinical trials management, data management, biostatistical anaylsis, medical communications services, clinical pharmacology, patient recruitment, regulatory and product development consulting, health policy and reimbursement, industry training and publishing, medical imaging services, interactive voice response systems, clinical trial management systems, web based portals, system integration, patient diary applications and other drug development services.
The company acquired APEX International Clinical Research Co in September 2007 and renamed it Parexel Apex International.
For more Conference Call related events or to post your own events, visit:
